Choose your language

Lung Cancer Forum 2026

This programme features expert‑led presentations and multidisciplinary discussion focused on translating the latest evidence into everyday practice. The meeting brings together delegates from across the EMEA region for a tailored, interactive agenda curated by our Scientific Committee, fostering scientific exchange at a regional level.

Scientific Committee:

Antonio Passaro, European Institute of Oncology, Milan, Italy
Noemí Reguart, Hospital Clinic i Provincial, Barcelona, Spain

Meeting Highlights

The sessions explore best practice in molecular testing, clinical data, dermatological care, nursing perspective, and practical patient management through plenary sessions and interactive workshops that fostered peer‑to‑peer exchange and practical applications. The forum also highlights the role of the wider care team to help optimise outcomes and the patient experience. With contributions from faculty across the EMEA region and beyond, the forum encourages scientific exchange and sharing of real‑world approaches to support consistent, high‑quality care.

The Scientific Committee outlined the following objectives for the 2026 meeting:

Understand the impact of the latest data updates in EGFR-mutant NSCLC on clinical practice
Understand the value of an MDT approach to optimise patient outcomes

Lung Cancer Forum 2027

Building on the success of our 2026 meeting, we are looking forward to planning our next annual meeting in 2027.

We’ll be sharing updates in the lead-up to our next annual gathering and look forward to keeping you informed.

On-demand video presentations

NSCLC & Pathology Overview

Expert Debate: First-Line EGFRm NSCLC

Partners in Care: The MDT Approach

Driving Innovation in Oncology: J&J’s Vision

Tackling Resistance in EGFRm NSCLC

Advancing Strategies for EGFR

Clinical Insights: Sharing Best Practice

AI in Action

Register with J&J Medical Cloud to access our full education library, including recordings, slides, and new session announcements.

Claim Your CPD Credit

The content of the Lung Cancer Forum video presentations has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim up to 6.5 CPD credits for this activity.

Please make a note of the following information to claim your CPD points:

Name of activity: Lung Cancer Forum 2026; 19th & 20th February 2026
Certificate number: 71417
Date of activity: 19th & 20th February 2026
CPD Provider: Sciterion (013096)

Abbreviations

EGFR, Epidermal growth factor receptor ; EGFRm, Epidermal growth factor receptor -mutated ; MDT, Multi-disciplinary team ; NSCLC, Non-small cell lung cancer